This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: No Stopping Apple (Final)

Stocks in this article: JNPR DE ORLY AZO PRU FSLR PCS NYB

Candid Talk

In an "Executive Decision" segment, Cramer sat down for a conversation with Chris Viehbacher, CEO of drug-maker Sanofi (SNY), another Action Alerts PLUS stock that's been hit hard thanks to the European contagion.

Viehbacher said that its clear that investors aren't paying close attention to the fundamentals at the moment, as none of the company's fundamentals has changed. He said that Sanofi is still committed to rewarding shareholders, which is why the company increased its dividend payout ratio and why he personally as purchased Sanofi stock recently.

Regarding the company's upcoming patent expirations, Viehbacher said he's tired of playing the "cat-and-mouse" game with investors and has opted to tell it like it is. He said that patents do expire and they do hurt a company's bottom line, but there is nothing they can do about it. Viehbacher said this will be his fourth "patent cliff," and Sanofi will continue to grow, even through the decline.

Among the bright spots has been Sanofi's acquisition of Genzyme. Viehbacher noted that biotech products have a better probably of success through research and development and they also aren't as impacted by generics since the drugs they produce are difficult to produce.

Other bright spots for the company included Sanofi's diabetes business, where the company is one of only two major players in the insulin market, as well as a drug for MS, which is seeing success in trials with only eight treatments over an 8-week period, followed by three treatments a year later. Viehbacher said patients on that regiment are seeing no relapses 60% of the time.

Finally, when asked about how government price controls are affecting the company, Viehbacher said that less than a third of Sanofi's business is subject to price controls, and the company is working to further diversify into other areas to avoid such pressures.

Cramer continued his recommendation for Sanofi, calling the company's European-induced slide the perfect buying opportunity.

Lightning Round

Cramer was bullish on Deere & Company (DE - Get Report), O'Reilly Automotive (ORLY - Get Report), AutoZone (AZO - Get Report) and Prudential (PRU - Get Report).

Cramer was bearish on First Solar (FSLR - Get Report), MetroPCS Communications (PCS) and New York Community Bancorp (NYB).

Opportune Time

In his "No Huddle Offense" segment, Cramer said that every negative cloud has a gold lining, and today's weakness in the precious metal is the perfect moment to start building a position.

In addition to owning gold bullion and the SPDR Gold Shares (GLD), Cramer said the time is finally right to start owning some individual gold stocks as well. He said that Newmont Mining (NEM) is talking about a dividend increase, while Agnico-Eagle Mines (AEM) has made some smart acquisitions.

Meanwhile, other miners like Rangold Resources (GOLD) and Goldcorp (GG) should finally start seeing their huge investments in mine expansions begin to bear fruit.

--Written by Scott Rutt in Washington, D.C.

To contact the writer of this article, click here: Scott Rutt.

To follow the writer on Twitter, go to

To submit a news tip, send an email to:

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.

For more of Cramer's insights during the Lightning Round, click here .

At the time of publication, Cramer was long Apple, Juniper Networks, Sanofi.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs